Evidence map›Paper›PMID 37374209›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.

Radha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam and 7 more

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Radha GopalaswamyICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.ORCID 0000-0001-8688-4617
Nandhini PalaniICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Dinesh ViswanathanICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Bershila PreysinghICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Suchithra RajendranICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Vaishnavee VijayaraghavanICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Kannadasan ThangavelICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Senthil Devi VadivelICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Hannah StanleyICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Kannan ThiruvengadamICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.ORCID 0000-0002-3758-1094
Lavanya JayabalDistrict TB, Chennai 600056, India.
Kaleeswari MurugesanDistrict TB, Kancheepuram 631502, India.
Sridhar RathinamGHTM, Tambaram, Chennai 600047, India.
Asha FrederickState TB, Sathumadural 600006, India.
Gomathi SivaramakrishnanICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
Chandrasekaran PadmapriyadarsiniICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.ORCID 0000-0002-1324-4595
Sivakumar ShanmugamICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsFluoroquinolonesHumansIndiaRetrospective StudiesAntitubercular AgentsFluoroquinolonesfluoroquinoloneLPAmutationsNGSresistancetreatment regimen

Identifiers

PMID37374209
PMCPMC10303903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.